For AH to suggest the growing number of failed or botched CRs has not played a part in managements diminishing - if not negative value to the company is ridiculous.
If it is true that we have a sales ready batch of concentrate from our tests (I believe I read this?) and we don't have anyone knocking to fund or get involved or take these tests to the next level, then it leaves me very concerned.
ah must go , page-5
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PEK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.62M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 5973 | 2 |
View Market Depth
| Last trade - 16.12pm 04/11/2024 (20 minute delay) ? |
| PEK (ASX) Chart |
Day chart unavailable